Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2020

View Archived Issues

First participant dosed in phase I study of SRN-14/GL2-800, a novel nucleic acid drug

Octapharma launches phase III superiority study of Panzyga in PANS

"Energy blueprint" maps how cells make, use ATP

C3AR1 as a novel biomarker for biliary atresia and primary sclerosing cholangitis

PPEF2 identified as potential new prognostic biomarker in HCC

S-62798 demonstrates efficacy in mouse model of thromboembolism

Palobiofarma reports promising phase II data on PBF-680 for asthma

MOSPD2 found as a therapeutic target for treating NASH

FDA grants accelerated approval to Gavreto for metastatic RET fusion-positive NSCLC

Purdue University compounds are active against vancomycin-resistant enterococcus

Denali Therapeutics identifies new EIF2B activators

New betulin acid derivatives discovered at Hetero Labs

Bristol-Myers Squibb discovers farnesoid X receptor agonists

New FGFR-4 inhibitors presented by BridGene Biosciences

Midwestern University describes isotopically stabilized tetronimide compounds

New severe aortic valve calcification and stenosis rabbit model developed

Northwestern University designs spherical nucleic acid triple-negative breast cancer vaccines

FluoGuide obtains Danish clearance for phase I/II trial of FG-001 to guide glioma surgery

Twist reports data on IgG antibodies and VHH nanobodies against SARS-CoV-2

Australian funding to support Pharmaxis' development of PXS-4699 for Duchenne muscular dystrophy

Akston signs up CRO to support phase I testing of COVID-19 vaccine candidate AKS-452

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...